Friess Associates LLC Assertio Holdings, Inc. Transaction History
Friess Associates LLC
- $59.9 Million
- Q2 2022
A detailed history of Friess Associates LLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Friess Associates LLC holds 766,650 shares of ASRT stock, worth $950,646. This represents 3.78% of its overall portfolio holdings.
Number of Shares
766,650
Previous 1,196,452
35.92%
Holding current value
$950,646
Previous $3.43 Million
34.13%
% of portfolio
3.78%
Previous 1.83%
Shares
3 transactions
Others Institutions Holding ASRT
# of Institutions
116Shares Held
44.7MCall Options Held
571KPut Options Held
275K-
Nantahala Capital Management, LLC New Canaan, CT9.27MShares$11.5 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.35MShares$7.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.92MShares$6.1 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.23MShares$4.01 Million0.01% of portfolio
-
Russell Investments Group, Ltd.2.35MShares$2.91 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $59.7M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...